The Australian Inflammatory Bowel Disease Microbiome Study - The AIM Study
- Conditions
- Inflammatory Bowel Diseaseulcerative colitiscolitisCrohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseOral and Gastrointestinal - Crohn's diseaseInflammatory and Immune System - Other inflammatory or immune system disorders
- Registration Number
- ACTRN12619000911190
- Lead Sponsor
- niversity of New South Wales
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 1000
Participants must be:
1.Aged between 6 to 80 years old at study entry
2.Able to give informed consent/assent
3.Confirmed CD or UC (Copenhagen criteria (adults) and Paediatric Crohn's disease Activity Index (PCDAI) and Paediatric Ulcerative colitis Activity Index (PUCAI) (physician global assessment) or newly-diagnosed
4.For control groups, no history of gastrointestinal inflammation or IBD
1.Female participants must not be pregnant or breast-feeding at time of recruitment into study
2.Unable to provide informed consent (patient or parent/carer) or comply with follow-up
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method